I-Oobli inyusa u-$18m woxhaso, ibambisene ne-Ingredion ukusheshisa amaprotheni amnandi

Isiqalo sephrotheni esimnandi sase-US i-Oobli sibambisene nenkampani yezithako zomhlaba wonke i-Ingredion, kanye nokuqongelela u-$18m oxhaso lwe-Series B1.

Ndawonye, ​​i-Oobli ne-Ingredion ihlose ukusheshisa imboni ukufinyelela kumasistimu e-sweetener anempilo, anambitheka kakhulu futhi athengekayo. Ngobambiswano, bazoletha izixazululo zemvelo ze-sweetener njenge-stevia kanye nezithako zamaphrotheni amnandi e-Oobli.

Amaprotheni amnandi ahlinzeka ngenye indlela enempilo esikhundleni sokusebenzisa ushukela kanye nama-sweeteners okwenziwa, afanele ukusetshenziswa ezinhlobonhlobo zokudla neziphuzo ezihlanganisa iziphuzo ezibandayo ezine-carbonated, izimpahla ezibhakiwe, iyogathi, i-confectionery nokunye.

Angasetshenziswa futhi ukuze agcwalise ngendlela engabizi kakhulu amanye amaswidi emvelo, ukusiza izinkampani zokudla ukuthi zithuthukise ubumnandi ngenkathi zihlangabezana nezinjongo zokudla kanye nokuphatha izindleko.

Lezi zinkampani ezimbili zisanda kuthuthukisa imikhiqizo ukuze ziqonde kangcono amathuba amaprotheni amnandi ne-stevia. Ubambiswano lwaqalwa kulandela impendulo eyakhayo eqoqwe ngemuva kwalezi zivivinyo. Ngenyanga ezayo, u-Ingredion no-Oobli bazokwembula eminye yentuthuko ezoba khona emcimbini we-Future Food Tech e-San Francisco, e-US, kusukela ngomhlaka-13-14 Mashi 2025.

Umjikelezo woxhaso we-Oobli ka-$18 wezigidi ze-Series B1 ubonise ukwesekwa okuvela kubatshalizimali abasha besu lokudla nezolimo, okuhlanganisa i-Ingredion Ventures, Lever VC kanye ne-Sucden Ventures. Abatshalizimali abasha bajoyina abalandeli abakhona, i-Khosla Ventures, i-Piva Capital ne-B37 Ventures phakathi kwabanye.

U-Ali Wing, oyi-CEO kwa-Oobli, uthe: “Amaphrotheni amnandi ayisengezo osekudlule isikhathi eside kusethi yamathuluzi ezinto ezinoshukela ezingcono kuwena.

U-Nate Yates ka-Ingredion, i-VP kanye no-GM wokunciphisa ushukela kanye ne-fiber fortification, kanye no-CEO webhizinisi lenkampani le-Pure Circle sweetener, uthe: "Sekuyisikhathi eside sihamba phambili ekusunguleni izixazululo zokunciphisa ushukela, futhi umsebenzi wethu ngamaphrotheni amnandi yisahluko esisha esijabulisayo kulolo hambo".

Ubuye wengeza wathi: “Noma ngabe sithuthukisa izinhlelo ezikhona ze-sweetener ngamaprotheni amnandi noma sisebenzisa ama-sweeteners ethu asungulwe ukuvula amathuba amasha, sibona ukusebenzisana okumangalisayo kuzo zonke lezi zinkundla”.

Ubambiswano lulandela izimemezelo zakamuva ze-Oobli zokuthi ithole izincwadi ze-US FDA GRAS 'akunamibuzo' zamaprotheni amabili amnandi (i-monellin ne-brazzein), eqinisekisa ukuphepha kwenoveli yamaphrotheni amnandi' ukuze isetshenziswe ekudleni nakwimikhiqizo yesiphuzo.

1


Isikhathi sokuthumela: Mar-10-2025